Connors Investor Services’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$239K Buy
+8,466
New +$198K 0.02% 138
2026
Q1
Sell
-8,766
Closed -$212K 153
2025
Q4
$212K Hold
8,766
0.02% 137
2025
Q3
$224K Buy
+8,766
New +$208K 0.02% 137
2025
Q2
Sell
-9,200
Closed -$210K 158
2025
Q1
$210K Sell
9,200
-300
-3% -$7.9K 0.02% 137
2024
Q4
$247K Sell
9,500
-700
-7% -$17.4K 0.02% 128
2024
Q3
$255K Hold
10,200
0.02% 131
2024
Q2
$219K Hold
10,200
0.02% 136
2024
Q1
$189K Hold
10,200
0.02% 149
2023
Q4
$166K Buy
+10,200
New +$130K 0.02% 147
2021
Q3
Sell
-5,911
Closed -$263K 164
2021
Q2
$263K Sell
5,911
-2,400
-29% -$84.6K 0.03% 139
2021
Q1
$299K Hold
8,311
0.03% 125
2020
Q4
$332K Sell
8,311
-1,800
-18% -$61.4K 0.04% 111
2020
Q3
$293K Hold
10,111
0.04% 111
2020
Q2
$165K Buy
+10,111
New +$139K 0.02% 127

Other funds holding BLFS

Connors Investor Services's BLFS Position: Q2 2026 in Review

Connors Investor Services opened a new position in BioLife Solutions (BLFS) in Q2 2026: 8,466 shares worth $239K. The stake represents 0.02% of the portfolio and ranks #138 among its holdings. This is a return to the name: Connors Investor Services previously reported a position in BLFS as recently as Q4 2025.

Connors Investor Services first reported a position in BLFS in Q2 2020 and has held it in 14 quarters since. The position peaked at $332K in Q4 2020. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Connors Investor Services held 8,466 shares of BioLife Solutions worth $239K as of Q2 2026.
  • BioLife Solutions was a new Connors Investor Services position in Q2 2026.
  • BioLife Solutions made up 0.02% of Connors Investor Services's portfolio in Q2 2026, its #138 holding.
  • Connors Investor Services first reported a position in BioLife Solutions in Q2 2020 and has held it in 14 quarters since.
  • Connors Investor Services's BioLife Solutions position peaked at $332K in Q4 2020.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Connors Investor Services's 13F filing for Q2 2026, filed 14 Aug 2026.